HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens

The effective discovery of tumor-specific antigens (TSAs) holds the key for the development of new diagnostic assays and immunotherapeutic approaches against cancer. Here, we discuss our recently developed technologies, HEPA and PARSE, which allow for the systematic identification of TSAs, generatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qing-Wen, Zhang, Yu, Wang, Xiao-Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661158/
https://www.ncbi.nlm.nih.gov/pubmed/23802073
http://dx.doi.org/10.4161/onci.23249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661158/
https://www.ncbi.nlm.nih.gov/pubmed/23802073
http://dx.doi.org/10.4161/onci.23249

Ejemplares similares